Pharmaceutical manufacturers of Mefenamic acid

Solara is an API manufacturer focused on research and customer satisfaction, operating in over 75 countries. They specialize in producing APIs for niche therapeutic categories, including complex products like polymer-based APIs and injectable APIs. The company has a team of experienced scientists supported by 6 manufacturing facilities and 2 R&D centers. Additionally, Solara offers Contract Research and Manufacturing Services (CRAMS) from discovery to late phase commercial manufacturing. Solara Active Pharma Sciences, with roots in Strides Shasun Ltd. and Sequent Scientific Ltd., is committed to providing value-based products while prioritizing customer needs. The company has 140+ scientists working at 2 R&D centers and 4 API manufacturing facilities, all with global approvals and 2 dedicated R&D facilities.

We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Società Italiana Medicinali Scandicci, known as S.I.M.S. srl, was established in Scandicci in 1937 by Mr Ugo Rangoni. During the 1950s and 1960s, it experienced growth in both production and personnel. In 1972, the first DMF (phenylbutazone) was presented to the FDA. The current API facility in Reggello has been operational since 1974 and has been regularly examined by the Agency ever since. Since the 1980s, the company has garnered increasing recognition in the field of custom-toll manufacturing through GMP status with major partners. The company has more than 20 APIs with registered DMF and, when applicable, the corresponding CEP.

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major trust area lies in Active Pharmaceutical Ingredient (API) Sales & Marketing in over 50 countries and Pan-India Formulation presence.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

DONGBANG FTL originated under the name Dongbang Synthetic Chemical with the aim of becoming the most well-known and reliable company in the active ingredients sector through honest competition

Yung Zip is an international professional bulk drug manufacturing company with customers distributed all over the world. In addition to supplying APIs, API intermediates and specialty chemicals, it also provides CRO and CMO services to customers both domestic and international. Yung Zip assists its customers with full suite support with chemical, manufacturing and control support for GMP-compliant API and drug manufacturing and registration over all stages of development.

To contribute to the advancement of society and industry through internal R&D; creating and marketing native products and processes; educating personnel; and advancement of science and technology. Designing, producing, and commercializing practical products and processes based on 'Sustainable Chemistry/Engineering Principles' through state-of-the-art internal R&D. To create local technologies. To enhance scientific and technical capabilities in crucial areas. Advancement of Science and Technology. Impacting and positively influencing the lives of at least one million individuals.

Here at Yamamoto Corporation, we take immense pride in our dedication to creating original concepts using innovative technologies and implementing these ideas into profitable and marketable products that offer tangible advantages to society. Our primary range of cutting-edge, high-efficiency, rubber-based materials is utilized in various sectors including professional sports, healthcare, aerospace, apparel, and numerous other industries. We are dedicated to leveraging these products to advance our goal of enhancing the lives of our clients by providing convenience, wellness, safety, and comfort.

Established in 2012, NIRA established an advanced manufacturing unit at GIDC, BAMANBORE, approximately 20 kilometers from RAJKOT, in the state of GUJARAT. This location is situated in a well-developed industrial area adjacent to the national highway connecting Rajkot and Ahmedabad. The company's primary objective is to engage in manufacturing, trading, export/import, brand establishment, and other related activities in the field of bulk drugs and their intermediates. Additionally, the company aims to establish, maintain, and operate research laboratories and experimental workshops for scientific and technical research and experimentation in India and worldwide.

Our products are mainly non-steroidal anti - inflammatory drugs.Non-steroidal anti-inflammatory drug can produce a moderate level of analgesic effect and the analgesic effect is mainly in the outer perimetis.It has good effect on chronic pain such as headache, joint and muscle pain and toothache.Anti-inflammatories are drugs that suppress inflammatory factors or release them.. By inhibiting the production of inflammatory factors, it reduces the inflammation, and it reduces the pain that the inflammation can cause.

Shandong Jincheng Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Zibo City, Shandong Province. Jincheng Pharma primarily focuses on the research and development, manufacturing, and promotion of pharmaceutical intermediates, active pharmaceutical ingredients, final pharmaceutical products, and general health products. It is recognized as the largest production and research center for cephalosporins side-chain intermediates and bio-fermentation API Glutathione globally. Additionally, it is a prominent domestic producer of anti-infection and gynecological preparations, and boasts the most comprehensive range of cephalosporin antibiotics and gynecological products throughout China.